abstract |
The present invention relates to a heterocyclic compound, a process for the preparation thereof, a pharmaceutical composition comprising the same, and optionally, in combination with other antibacterial agents and/or β-endoyamine compounds, for the prevention or treatment of bacterial infections. The invention also relates to the use of such compounds as beta-endosaminolase inhibitors and/or as antibacterial agents. |